Developing targeted antimalarial drug leads from host defence peptide-drug conjugates
Researchers
- Associate Professor Brendan McMorran (Primary Investigator)
- Professor Lara Malins (Secondary Investigator)
Grant status
Completed-Pending ReportsGrant start date
01/01/2020Grant funding
- 2020: $385,104 from National Health and Medical Research Council (NHMRC)
- 2021: $372,954 from National Health and Medical Research Council (NHMRC)
- 2022: $304,979 from National Health and Medical Research Council (NHMRC)
